DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Australia Market Report for Pelvic Organ Prolapse Repair 2017 - MedCore" report to their offering.
The market has begun and is expected to continue a substantial shift from transvaginal mesh to sacrocolpopexy mesh. While transvaginal mesh sales currently comprise the majority of the market, their dominance will decrease as physicians move towards sacrocolpopexy mesh at increasing rates. While the FDA warnings issued in 2011 had the greatest effect on the United States market, the Australian market was also heavily impacted.
The impact was disproportionately higher in Anglophone countries and countries without fully public healthcare systems, possibly because of the high degree of cross-over in negative press as well as the increased patient costs associated with repeat procedures. Modifications to the mesh, extra clinical trials to prove safety and pre-emptive marketing is helping to clarify the safety and health risks associated with mesh to curb the decline in procedures.
Even though the transvaginal mesh market is declining, a smaller but solid demand for this product will remain over the forecast period.
Key Topics Covered:
1. Research Methodology
2. Disease Overview
3. Product Assessment
4. Pelvic Organ Prolapse Repair Device Market
For more information about this report visit http://www.researchandmarkets.com/research/nttgxg/australia_market